New England Research & Management, Inc. Buys 1, Sells 4 in 3rd Quarter

New England Research & Management, Inc. recently filed their 13F report for the third quarter of 2022, which ended on 2022-09-30.

The 13F report details which stocks were in a guru’s equity portfolio at the end of the quarter, though investors should note that these filings are limited in scope, containing only a snapshot of long positions in U.S.-listed stocks and American depository receipts as of the quarter’s end. They are not required to include international holdings, short positions or other types of investments. Still, even this limited filing can provide valuable information.

53 W. JACKSON BLVD. CHICAGO, IL 60604

As of the latest 13F report, the guru’s equity portfolio contained 156 stocks valued at a total of $159.00Mil. The top holdings were JNJ(3.04%), CHD(2.71%), and MSFT(2.59%).

According to GuruFocus data, these were New England Research & Management, Inc.’s top five trades of the quarter.

Cheniere Energy Inc


The guru sold out of their 20,000-share investment in AMEX:LNG. Previously, the stock had a 1.55% weight in the equity portfolio. Shares traded for an average price of $151.67 during the quarter.

On 10/06/2022, Cheniere Energy Inc traded for a price of $173.66 per share and a market cap of $43.53Bil. The stock has returned 77.72% over the past year.

GuruFocus gives the company a financial strength rating of 3 out of 10 and a profitability rating of 4 out of 10.

In terms of valuation, Cheniere Energy Inc has a EV-to-Ebitda ratio of -662.07 and a price-sales ratio of 1.76.

The price-to-GF Value ratio is 0.94, earning the stock a GF Value rank of 6.

Walmart Inc


New England Research & Management, Inc. reduced their investment in NYSE:WMT by 15,993 shares. The trade had a 1.13% impact on the equity portfolio. During the quarter, the stock traded for an average price of $131.42.

On 10/06/2022, Walmart Inc traded for a price of $132.78 per share and a market cap of $360.26Bil. The stock has returned -1.93% over the past year.

GuruFocus gives the company a financial strength rating of 6 out of 10 and a profitability rating of 8 out of 10.

In terms of valuation, Walmart Inc has a price-earnings ratio of 26.49, a price-book ratio of 4.65, a price-earnings-to-growth (PEG) ratio of 6.62, a EV-to-Ebitda ratio of 13.25 and a price-sales ratio of 0.63.

The price-to-GF Value ratio is 0.88, earning the stock a GF Value rank of 6.

C.H. Robinson Worldwide Inc


The guru sold out of their 13,675-share investment in NAS:CHRW. Previously, the stock had a 0.81% weight in the equity portfolio. Shares traded for an average price of $107.45 during the quarter.

On 10/06/2022, C.H. Robinson Worldwide Inc traded for a price of $98.49 per share and a market cap of $12.20Bil. The stock has returned 13.51% over the past year.

GuruFocus gives the company a financial strength rating of 6 out of 10 and a profitability rating of 9 out of 10.

In terms of valuation, C.H. Robinson Worldwide Inc has a price-earnings ratio of 11.85, a price-book ratio of 6.01, a price-earnings-to-growth (PEG) ratio of 3.20, a EV-to-Ebitda ratio of 9.70 and a price-sales ratio of 0.49.

The price-to-GF Value ratio is 0.71, earning the stock a GF Value rank of 9.

Abbott Laboratories


New England Research & Management, Inc. reduced their investment in NYSE:ABT by 12,324 shares. The trade had a 0.78% impact on the equity portfolio. During the quarter, the stock traded for an average price of $106.59.

On 10/06/2022, Abbott Laboratories traded for a price of $102.27 per share and a market cap of $179.27Bil. The stock has returned -10.52% over the past year.

GuruFocus gives the company a financial strength rating of 7 out of 10 and a profitability rating of 9 out of 10.

In terms of valuation, Abbott Laboratories has a price-earnings ratio of 21.38, a price-book ratio of 4.91, a price-earnings-to-growth (PEG) ratio of 0.98, a EV-to-Ebitda ratio of 13.38 and a price-sales ratio of 3.99.

The price-to-GF Value ratio is 0.78, earning the stock a GF Value rank of 9.

United Therapeutics Corp


The guru established a new position worth 5,550 shares in NAS:UTHR, giving the stock a 0.73% weight in the equity portfolio. Shares traded for an average price of $223.56 during the quarter.

On 10/06/2022, United Therapeutics Corp traded for a price of $208.24 per share and a market cap of $9.48Bil. The stock has returned 8.59% over the past year.

GuruFocus gives the company a financial strength rating of 8 out of 10 and a profitability rating of 8 out of 10.

In terms of valuation, United Therapeutics Corp has a price-earnings ratio of 15.75, a price-book ratio of 2.19, a EV-to-Ebitda ratio of 9.17 and a price-sales ratio of 5.58.

The price-to-GF Value ratio is 1.09, earning the stock a GF Value rank of 3.


Please note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.

Want to provide feedback on this article? Have questions or concerns? Get in touch with us here, or email us at [email protected]!

This article is general in nature and does not represent the opinions of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendations. It was written without regard to your individual situation or financial goals. We aim to bring you fundamental, data-driven analysis, The information on this site is in no way guaranteed for completeness, accuracy or in any other way.